Inadequate vitamin D status has been linked to increased risk of type 2 diabetes and
cardiovascular disease. Inducible cyclooxygenase (COX) isoform COX-2 has been involved in the …

Background Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH),
is a type of pulmonary vascular disease characterized by abnormal contraction and …

Cardiovascular disease (CVD) is the most fatal disease that causes sudden death, and
inflammation contributes substantially to its occurrence and progression. The prevalence of CVD …

Pulmonary arterial hypertension (PAH) is commonly associated with chronic hypoxemia in
disorders such as chronic obstructive pulmonary disease (COPD). Prostacyclin analogs are …

Rationale: Vascular remodeling, including smooth muscle cell hypertrophy and proliferation,
is the key pathological feature of pulmonary arterial hypertension (PAH). Prostaglandin I 2 …

Rationale: Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary
vascular remodeling, accompanied by varying degrees of perivascular inflammation. Niacin…

Aims Extracellular matrix (ECM) proteins accumulation contributes to the progression of
pulmonary arterial hypertension (PAH), a rare and fatal cardiovascular condition defined by high …

Objective— Macrophages participate in the pathogenesis of pulmonary arterial hypertension
(PAH). Lgmn (Legumain), a newly discovered cysteine proteinase belonging to the C13 …

Introduction Vascular smooth muscle cell (VSMC) senescence in the vasculature results in
vascular aging as well as age-related diseases, while metformin improves the inflamm-aging …

The contractile-synthetic phenotypic conversion of vascular smooth muscle cells (VSMCs)
plays a key role in atherosclerosis, vascular restenosis, and hypertension. Our previous study …